Literature DB >> 9791731

Cell surface activation of progelatinase A (proMMP-2) and cell migration.

H Nagase1.   

Abstract

Gelatinase A (MMP-2) is considered to play a critical role in cell migration and invasion. The proteinase is secreted from the cell as an inactive zymogen. In vivo it is postulated that activation of progelationase A (proMMP-2) takes place on the cell surface mediated by membrane-type matrix metalloproteinases (MT-MMPs). Recent studies have demonstrated that proMMP-2 is recruited to the cell surface by interacting with tissue inhibitor of metalloproteinases-2 (TIMP-2) bound to MT1-MMP by forming a ternary complex. Free MT1-MMP closely located to the ternary complex then activates proMMP-2 on the cell surface. MT1-MMP is found in cultured invasive cancer cells at the invadopodia. The MT-MMP/TIMP-2/MMP-2 system thus provides localized expression of proteolysis of the extracellular matrix required for cell migration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9791731     DOI: 10.1038/cr.1998.18

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  48 in total

Review 1.  A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

Authors:  L Yan; M A Moses
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Roles of Matrix Metalloproteinases and ECM Remodeling during Thyroid Hormone-Dependent Intestinal Metamorphosis in Xenopus laevis.

Authors:  Liezhen Fu; Takashi Hasebe; Atsuko Ishizuya-Oka; Yun-Bo Shi
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

3.  Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut.

Authors:  Emily K Robinson; Daniel P Kelly; David W Mercer; Rosemary A Kozar
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Jul-Aug       Impact factor: 4.016

4.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

5.  TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin.

Authors:  Luciana C Mazzocchi; Christine U Vohwinkel; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-13       Impact factor: 5.464

6.  Quantitative proteomics reveals altered expression of extracellular matrix related proteins of human primary dermal fibroblasts in response to sulfated hyaluronan and collagen applied as artificial extracellular matrix.

Authors:  Stephan A Müller; Anja van der Smissen; Margarete von Feilitzsch; Ulf Anderegg; Stefan Kalkhof; Martin von Bergen
Journal:  J Mater Sci Mater Med       Date:  2012-09-19       Impact factor: 3.896

Review 7.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

8.  Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.

Authors:  Lian-Xin Liu; Zhi-Hua Liu; Hong-Chi Jiang; Xin Qu; Wei-Hui Zhang; Lin-Feng Wu; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Mutational analysis of the cleavage of the cancer-associated laminin receptor by stromelysin-3 reveals the contribution of flanking sequences to site recognition and cleavage efficiency.

Authors:  Maria Fiorentino; Liezhen Fu; Yun-Bo Shi
Journal:  Int J Mol Med       Date:  2009-03       Impact factor: 4.101

10.  Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Authors:  Laura A Maile; Byron E Capps; Emily C Miller; Lee B Allen; Umadevi Veluvolu; Ariel W Aday; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.